The genetic/metabolic transformation concept of carcinogenesis

Cancer and Metastasis Reviews

Volumn 31, Issue 1-2, 2012, Pages 123-130

  Costello, Leslie C ^a   Franklin, Renty B ^a  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

Carcinogenesis; Genetic metabolic transformation; Metabolic malignant transformation; Tumor metabolism

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

BIOENERGY; CANCER CELL; CANCER GENETICS; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CARCINOMA IN SITU; CELL ACTIVITY; CELL GROWTH; CELL METABOLISM; CELL PROLIFERATION; GENETIC TRANSFORMATION; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEOMICS; REVIEW;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MALE; PROSTATIC NEOPLASMS; PROTEOME; TUMOR MICROENVIRONMENT;

EID: 84862309035     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-011-9334-8     Document Type: Review

References (28)

1. Vogelstein, B., & Kinzler, K. W. (2004). Cancer genes and the pathways they control. Nature Medicine, 10(8), 789-799. (Pubitemid 39070849)
2. Costello, L. C., & Franklin, R. B. (2005). 'Why do tumour cells glycolyse?': from glycolysis through citrate to lipogenesis. Molecular and Cellular Biochemistry, 280(1-2), 1-8. (Pubitemid 41829794)
3. Costello, L. C., & Franklin, R. B. (2006). The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Molecular Cancer. doi:10.1186/1476-4598-5-17.
4. Costello, L. C., & Franklin, R. B. (2009). Integration of genetic, proteomic, and metabolic approaches in tumor cell metabolism. In K. Singh & L. C. Costello (Eds.), Mitochondria and cancer (pp. 79-92). New York: Springer.
5. Costello, L. C.,&Franklin, R. B. (2008). Transformations of malignant cells (an overview). In M. A. Hayat (Ed.), Methods of cancer diagnosis, therapy, and prognosis (pp. 3-16). New York: Springer.
6. Baggetto, L. G. (1992). Deviant energetic metabolism of glycolytic cancer cells. Biochimie, 74(11), 959-974.
7. Kasper, S. (2008). Stem cells: the root of prostate cancer? Journal of Cell Physiology, 216(2), 332-336.
8. Dang, C. V., & Samenza, G. L. (1999). Oncogenic alterations of metabolism. Trends in Biological Sciences, 24(2), 68-72. (Pubitemid 29346576)
9. Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100(1), 57-70. (Pubitemid 30046295)
10. Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646-674.
11. Alqawi, O., Wang, H. P., Espiritu, M., & Singh, G. (2007). Chronic hypoxia promotes an aggressive phenotype in rat prostate cancer cells. Free Radical Research, 41(7), 788-797. (Pubitemid 46995260)
12. Warburg, O., Wind, F., & Negelein, E. (1927). The metabolism of tumors in the body. Journal of General Physiology, 8(6), 519-530.
13. Moreadith, R. W., & Lehninger, A. L. (1984). The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme. Journal of Biological Chemistry, 59(10), 6215-6221. (Pubitemid 14106333)
14. Warburg, O. (1956). On the origin of cancer cells. Science, 123 (3191), 309-314.
15. Weinhouse, S., Warburg, O., Burk, D., & Schade, A. L. (1956). On respiratory impairment in cancer cells. Science, 123(3191), 309-314.
16. Seyfried, T. N., & Shelton, L. M. (2010). Cancer as a metabolic disease. Nutrition and Metabolism. doi:10.1186/1743-7075-7-7.
17. Huggins, C. (1946). The prostate secretion. Harvey Lectures, 42, 148-193.
18. Costello, L. C., Guan, Z., Kukoyi, B., Feng, P., & Franklin, R. B. (2004). Terminal oxidation and the effects of zinc in prostate versus liver mitochondria. Mitochondrion, 4(4), 331-338. (Pubitemid 40045659)
19. Costello, L. C., Franklin, R. B., & Feng, P. (2005). Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer. Mitochondrion, 5(3), 143-153. (Pubitemid 40823303)
20. Franklin, R. B., & Costello, L. C. (2007). Zinc as an anti-tumor agent in prostate cancer and in other cancers. Archives of Biochemistry and Biophysics, 463(2), 211-217. (Pubitemid 47030335)
21. Franklin, R. B., Feng, P., Milon, B. C., Desouki, M. M., Singh, K. K., Kajdacsy-Balla, A., et al. (2005). hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Molecular Cancer, 4(32), 13.
22. Cortesi, M., Fridman, E., Volkov, A., Shilstein, S. S., Chechik, R., Breskin, A., Vartsky, D., Kleinman, N., Kogan, G., Moriel, E., Gladysh, V., Huszar, M., Ramon, J., Raviv, G., et al. (2008). Clinical assessment of the cancer diagnostic value of prostatic zinc: a comprehensive needle-biopsy study. Prostate, 68(9), 994- 1006.
23. Johnson, L. A., Kanak, M. A., Kajdacsy-Balla, A., Pestaner, J. P., & Bagasra, O. (2010). Differential zinc accumulation and expression of human zinc transporter 1 (hZIP1) in prostate glands. Methods, 52(4), 316-321.
24. Cooper, J. E., & Farid, I. (1964). The role of citric acid in the physiology of the prostate: lactic/citrate ratios in benign and malignant prostatic homogenates as an index of prostatic malignancy. Journal of Urology, 92, 533-536.
25. Costello, L. C.,& Franklin, R. B. (2006). Tumor cell metabolism: the marriage of molecular genetics and proteomics with cellular intermediary metabolism; proceed with caution! Molecular Cancer. doi:10.1186/1476-4598-5-59.
26. Costello, L. C. (2009). The effect of contemporary education and training of biomedical scientists on present and future medical research. Academic Medicine, 84(4), 459-463.
27. Singh, K. K., Desouki, M. M., Franklin, R. B., Costello, L. C. Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. Molecular Cancer, doi:10.1186/1476-4598-5-14.
28. Costello, L. C., Littleton, G. K., & Franklin, R. B. (1978). Regulation of citrate-related metabolism in normal and neoplastic prostate. In R. K. Sharma & W. E. Criss (Eds.), Endocrine control in neoplasia (pp. 303-314). New York: Raven.